Erratum: Differential CARM1 isoform expression in subcellular compartments and among malignant and benign breast tumors (PLoS ONE (2015) 10:6 (e0128143) DOI: 10.1371/journal.pone.0128143);Differential CARM1 isoform expression in subcellular compartments and among malignant and benign breast tumors

PLoS ONE

Volumn 10, Issue 6, 2015, Pages

  Shlensky, David ^a   Mirrielees, Jennifer A ^a   Zhao, Zibo ^a   Wang, Lu ^a   Mahajan, Aparna ^a   Yu, Menggang ^a   Sherer, Nathan M ^a   Wilke, Lee G ^a   Xu, Wei ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COACTIVATOR ASSOCIATED ARGININE METHYLTRANSFERASE 1; HEAT SHOCK PROTEIN 90; MESSENGER RNA; PROTEIN ARGININE METHYLTRANSFERASE; UNCLASSIFIED DRUG; BENZOQUINONE DERIVATIVE; COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1; ISOENZYME; MACROCYCLIC LACTAM; TANESPIMYCIN;

ARTICLE; BG 1 CELL LINE; BREAST FIBROADENOMA; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; ENZYME INHIBITION; GROWTH INHIBITION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; LYMPH NODE; MDA MB 231 CELL LINE; NUCLEAR LOCALIZATION SIGNAL; PROTEIN EXPRESSION; TUMOR VOLUME; ANTAGONISTS AND INHIBITORS; BREAST NEOPLASMS; DEFICIENCY; DIFFERENTIAL DIAGNOSIS; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENE INACTIVATION; GENETICS; INTRACELLULAR SPACE; METABOLISM; PATHOLOGY; PROTEIN TRANSPORT; TUMOR CELL LINE;

BENZOQUINONES; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CYTOPLASM; DIAGNOSIS, DIFFERENTIAL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKOUT TECHNIQUES; HSP90 HEAT-SHOCK PROTEINS; HUMANS; INTRACELLULAR SPACE; ISOENZYMES; LACTAMS, MACROCYCLIC; PROTEIN TRANSPORT; PROTEIN-ARGININE N-METHYLTRANSFERASES;

EID: 84934888396     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0131955     Document Type: Erratum

References (29)

1. Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. J Clin Oncol. 2010 Ju. 1;28(1):2784-95. doi:10.1200/JCO.2009.25.6529 PMID:20404251
2. Wolff AC, Hammond ME, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update. Arch Pathol Lab Med. 2014 Feb; 138(2):241-56. doi:10.5858/arpa.2013-0953-SA PMID:24099077
3. Zanotti L, Bottini A, Rossi C, Generali D, Cappelletti MR. Diagnostic tests based on gene expression profile in breast cancer: from background to clinical use. Tumour Biol. 2014 Jul. 23.
4. Couch FJ, Nathanson KL, Offit K. Two decades after BRCA: setting paradigms in personalized cancer care and prevention. Science. 2014 Mar. 28;343(6178):1466-70. doi:10.1126/science.1251827 PMID:24675953
5. Kuhn P, Xu W. Protein arginine methyltransferases: nuclear receptor coregulators and beyond. Prog Mol Biol Transl Sci. 2009;87:299-342. doi:10.1016/S1877-1173 (09) 87009-9 PMID:20374708
6. Wang L, Zhao Z, Meyer MB, Saha S, Yu M, Guo A, et al. CARM1 methylates chromatin remodeling factor BAF155 to enhance tumor progression and metastasis. Cancer Cell. 2014 Jan 13;25(1):21-36. doi:10.1016/j.ccr.2013.12.007 PMID:24434208
7. Lee YH, Coonrod SA, Kraus WL, Jelinek MA, Stallcup MR. Regulation of coactivator complex assembly and function by protein arginine methylation and demethylimination. Proc Natl Acad Sci USA 2005, 102(10):3611-3616. PMID:15731352
8. Cheng D, Cote J, Shaaban S, Bedford MT. The arginine methyltransferase CARM1 regulates the coupling of transcription and mRNA processing. Mol Cell 2007, 25(1):71-83. PMID:17218272
9. Kuhn P, Xu W: Protein arginine methyltransferases: nuclear receptor coregulators and beyond. Prog Mol Biol Transl Sci 2009, 87:299-342. doi:10.1016/S1877-1173 (09) 87009-9 PMID:20374708
10. Yadav N, Lee J, Kim J, Shen J, Hu MC, Aldaz CM, et al. Specific protein methylation defects and gene expression perturbations in coactivator-associated arginine methyltransferase 1-deficient mice. Proc Natl Acad Sci USA. 2003 May 27;100(11):6464-8. PMID:12756295
11. Elakoum R, Gauchotte G, Oussalah A, Wissler MP, Clement-Duchene C, Vignaud JM, et al. CARM1 and PRMT1 are dysregulated in lung cancer without hierarchical features. Biochimie. 2014 Feb; 97:210-8. doi:10.1016/j.biochi.2013.10.021 PMID:24211191
12. Kim YR, Lee BK, Park RY, Nguyen NT, Bae JA, Kwon DD, et al. Differential CARM1 expression in prostate and colorectal cancers. BMC Cancer. 2010 May 13;10:197. doi:10.1186/1471-2407-10-197 PMID:20462455
13. Osada S, Suzuki S, Yoshimi C, Matsumoto M, Shirai T, Takahashi S, et al. Elevated expression of coactivator-associated arginine methyltransferase 1 is associated with early hepatocarcinogenesis. Oncol Rep. 2013 Oct; 30(4):1669-74. doi:10.3892/or.2013.2651 PMID:23912631
14. Moulick K, Ahn JH, Zong H, Rodina A, Cerchietti L, Gomes Da Gama EM, et al. Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90. Nat Chem Biol. 2011 Sep. 25;7(11):818-26. doi:10.1038/nchembio.670 PMID:21946277
15. Bedford MT, Clarke SG. Protein arginine methylation in mammals: who, what, and why. Mol Cell. 2009 Jan 16;33(1):1-13. doi:10.1016/j.molcel.2008.12.013 PMID:19150423
16. El Messaoudi S, Fabbrizio E, Rodriguez C, Chuchana P, Fauquier L, Cheng D, et al. Coactivator-associated arginine methyltransferase 1 (CARM1) is a positive regulator of the Cyclin E1 gene. Proc Natl Acad Sci USA. 2006 Sep. 5;103(36):13351-6. PMID:16938873
17. Frietze S, Lupien M, Silver PA, Brown M. CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1. Cancer Res. 2008 Jan 1;68(1):301-6. doi:10.1158/0008-5472. CAN-07-1983 PMID:18172323
18. Al-Dhaheri M, Wu J, Skliris GP, Li J, Higashimato K, Wang Y, et al. CARM1 is an important determinant of ERα-dependent breast cancer cell differentiation and proliferation in breast cancer cells. Cancer Res. 2011 Mar. 15;71(6):2118-28. doi:10.1158/0008-5472. CAN-10-2426 PMID:21282336
19. Wang L, Charoensuksai P, Watson NJ, Wang X, Zhao Z, Coriano CG, et al. CARM1 automethylation is controlled at the level of alternative splicing. Nucleic Acids Res 2013.
20. Davis MB, Liu X, Wang S, Reeves J, Khramtsov A, Huo D, et al. Expression and sub-cellular localization of an epigenetic regulator, co-activator arginine methyltransferase 1(CARM1), is associated with specific breast cancer subtypes and ethnicity. Mol Cancer 2013, 12(1):40. doi:10.1186/1476-4598-12-40 PMID:23663560
21. McGuire WL, Chamness GC, Fuqua SA. Estrogen receptor variants in clinical breast cancer. Mol Endocrinol. 1991;5:1571-7. PMID:1779964
22. Badve S, Nakshatri H. Oestrogen-receptor-positive breast cancer: towards bridging histopathological and molecular classifications. J Clin Pathol. 2009;62:6-12. doi:10.1136/jcp. 2008.059899 PMID:18794199
23. Clark GM, Osborne CK, McGuire WL. Correlations between estrogen receptor, progesterone receptor, and patient characteristics in human breast cancer. J Clin Oncol. 1984;2:1102-9. PMID:6491696
24. Osborne CK, Yochmowitz MG, Knight WA 3rd, McGuire WL. The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer. 1980;46:2884-8. PMID:7448733
25. Habashy HO, Rakha EA, Ellis IO, Powe DG. The oestrogen receptor coactivator CARM1 has an oncogenic effect and is associated with poor prognosis in breast cancer. Breast Cancer Res Treat. 2013 Jul; 140(2):307-16. doi:10.1007/s10549-013-2614-y PMID:23887673
26. Wang L, Charoensuksai P, Watson NJ, Wang X, Zhao Z, Coriano CG, et al. CARM1 automethylation is controlled at the level of alternative splicing. Nucleic Acids Res. 2013 Aug; 41(14):6870-80. doi:10. 1093/nar/gkt415 PMID:23723242
27. Moulick K, Ahn JH, Zong H, Rodina A, Cerchietti L, Gomes DaGama EM, et al. Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90. Nat Chem Biol. 2011 Sep. 25;7(11):818-26. doi:10.1038/nchembio.670 PMID:21946277
28. Mann M, Cortez V, Vadlamudi R. PELP1 oncogenic functions involve CARM1 regulation. Carcinogenesis. 2013 Jul; 34(7):1468-75. doi:10.1093/carcin/bgt091 PMID:23486015
29. Cheng H, Qin Y, Fan H, Su P, Zhang X, Zhang H, et al. Overexpression of CARM1 in breast cancer is correlated with poorly characterized clinicopathologic parameters and molecular subtypes. Diagn Pathol. 2013 Aug. 2;8:129. doi:10.1186/1746-1596-8-129 PMID:23915145